LC/HRMS, LC/MS, LC/MS/MS, LC/Orbitrap
IndustriesPharma & Biopharma, Proteomics
ManufacturerThermo Fisher Scientific
Significance of the Topic
Peptide mapping by liquid chromatography–mass spectrometry (LC-MS) is essential for confirming the primary structure of biotherapeutic proteins and monitoring post-translational modifications. While trypsin is the most common protease, it can generate peptides that are too short or too hydrophilic to retain on reversed-phase columns. Chymotrypsin offers complementary cleavage specificity at aromatic residues, improving sequence coverage. Automating this digestion enhances reproducibility and throughput in protein characterization workflows.
Goals and Overview of the Study
This work aimed to develop and validate a robust, high-precision automated workflow for chymotrypsin peptide mapping. Using recombinant somatotropin as a model, the study demonstrated an easy-to-use, reproducible protocol that achieves full sequence coverage and serves as an orthogonal alternative to trypsin digestion in biotherapeutic analysis.
Methodology
A magnetic bead–based chymotrypsin digestion was performed on the Thermo Scientific KingFisher Duo Prime system. Chymotrypsin resin was suspended in buffer and combined with the protein sample in a dedicated incubation lane. Digestion was carried out at 70 °C for 15 minutes with controlled mixing. After incubation, magnetic beads were removed and the digest was cooled to 15 °C.
Instrumentation
- Thermo Scientific KingFisher Duo Prime purification system
- Magnetic SMART Digest™ Chymotrypsin Kit
- Thermo Scientific Vanquish™ Horizon UHPLC with Acclaim™ VANQUISH™ C18 column (2.1 × 250 mm)
- Thermo Scientific Q Exactive™ Plus Hybrid Quadrupole-Orbitrap mass spectrometer
- Xcalibur™ and BioPharma Finder™ software for data acquisition and analysis
Main Results and Discussion
Three replicate 15-minute automated digests of somatotropin yielded 100 % sequence coverage and high reproducibility (average peptide area RSD 3.6 %, with key peptides below 2.2 %). Time-course experiments revealed that chymotrypsin initially cleaves at aromatic residues (Trp, Tyr, Phe) and progressively at secondary sites (Leu, Met, His) over extended digestion. Precise timing prevents overdigestion and complex peptide mixtures. Comparative mapping with trypsin highlighted that chymotrypsin produces longer, more hydrophobic peptides that are readily retained and detected, resolving regions where trypsin generated unretained dipeptides.
Benefits and Practical Applications
- Orthogonal digestion specificity complements trypsin workflows
- High reproducibility and throughput enabled by automation
- Improved detection of peptides that are poorly retained after trypsin digestion
- Controlled digestion time minimizes overdigestion and simplifies data interpretation
Future Trends and Applications
- Integration of automated protease workflows into high-throughput biopharmaceutical pipelines
- Extension of magnetic bead–based automation to other proteases for targeted PTM analysis
- Combination with advanced data analysis and machine learning for deeper sequence characterization
- Development of end-to-end automated platforms for comprehensive protein characterization
Conclusion
Automated magnetic SMART chymotrypsin digestion on the KingFisher Duo Prime platform provides a robust, reproducible alternative to trypsin for peptide mapping. Controlled digestion and high-resolution LC-MS analysis deliver complete sequence coverage and orthogonal specificity, enhancing the reliability of biotherapeutic protein characterization.
References
- Farrell A, Bones J, Cook K. Application Note 21834: Automated chymotrypsin peptide mapping of proteins by LC-MS. Thermo Fisher Scientific; 2018.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.